4//SEC Filing
Jewell Christopher M 4
Accession 0001453687-24-000026
CIK 0001453687other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:08 PM ET
Size
552.7 KB
Accession
0001453687-24-000026
Insider Transaction Report
Form 4
Jewell Christopher M
Chief Scientific Officer
Transactions
- Award
Common Stock
2024-01-02+778,200→ 778,200 total - Award
Employee Stock Option (right to buy)
2024-01-02+998,000→ 998,000 totalExercise: $0.66Exp: 2034-01-01→ Common Stock (998,000 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028.
- [F2]This option vests as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028.
Issuer
Cartesian Therapeutics, Inc.
CIK 0001453687
Entity typeother
Related Parties
1- filerCIK 0002000226
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:08 PM ET
- Size
- 552.7 KB